Latest News
Sun Pharma Advanced Research Company Limited
- Sun Pharma Advanced Research Co. Ltd. Estimates – BSE:SPARC
- Sun Pharma Advanced Research Company Stock Price Forecast. Should You Buy SPARC.NS?
- Sun Pharma Advanced Research Q1 Loss Widens To Rs 36 Crore
- Sun Pharma Advanced Research Wins CESTAT Ruling, Secures Rs 27.51 Cr CENVAT Refund
- Sun Pharma Advanced Research Wins Rs 27.51 Crore CENVAT Credit Refund Dispute, Tribunal Dismisses Revenue's Appeal
- Sun Pharma Advanced Research wins ₹28 crore CENVAT credit refund case in CESTAT
- CESTAT upholds ₹2,751 lakh CENVAT credit refund for Sun Pharma Advanced Research
- Sun Pharma Advanced Research (SPARC.NS) Slips 1.55% to ₹194.13 as Traders Watch ₹184 Support Zone - Collar Trade
Headlines from the last 30 days, linking to the original publishers. See all market news →